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OBJECTIVE: To compare the repetitive DNA patterns of human actinic keratoses and squamous cell carcinomas to
determine the genetic alterations that are associated with malignant transformation.
INTRODUCTION: Cancer cells are prone to genomic instability, which is often due to DNA polymerase slippage
during the replication of repetitive DNA and to mutations in the DNA repair genes. The progression of benign
actinic keratoses to malignant squamous cell carcinomas has been proposed by several authors.
MATERIAL AND METHODS: Eight actinic keratoses and 24 squamous cell carcinomas (SCC), which were pair-matched
to adjacent skin tissues and/or leucocytes, were studied. The presence of microsatellite instability (MSI) and the loss
of heterozygosity (LOH) in chromosomes 6 and 9 were investigated using nine PCR primer pairs. Random Amplified
Polymorphic DNA patterns were also evaluated using eight primers.
RESULTS: MSI was detected in two (D6S251, D9S50) of the eight actinic keratosis patients. Among the 8 patients
who had squamous cell carcinoma-I and provided informative results, a single patient exhibited two LOH (D6S251,
D9S287) and two instances of MSI (D9S180, D9S280). Two LOH and one example of MSI (D6S251) were detected in
three out of the 10 patients with squamous cell carcinoma-II. Among the four patients with squamous cell
carcinoma-III, one patient displayed three MSIs (D6S251, D6S252, and D9S180) and another patient exhibited an MSI
(D9S280). The altered random amplified polymorphic DNA ranged from 70% actinic keratoses, 76% squamous cell
carcinoma-I, and 90% squamous cell carcinoma-II, to 100% squamous cell carcinoma-III.
DISCUSSION: The increased levels of alterations in the microsatellites, particularly in D6S251, and the random
amplified polymorphic DNA fingerprints were statistically significant in squamous cell carcinomas, compared with
actinic keratoses.
CONCLUSION: The overall alterations that were observed in the repetitive DNA of actinic keratoses and squamous
cell carcinomas indicate the presence of a spectrum of malignant progression.
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INTRODUCTION
Skin cancer is a multistep genetic disease that results from
the accumulation of mutations in genes that are related to
the cell cycle and the DNA repair systems at the root of
genomic instability in tumor cells. Squamous cell carcino-
mas (SCCs) result from the malignant transformation of
keratinocytes that reside in the squamous-cell layer of the
epidermis, giving rise to primary tumors that metastasize in
approximately 2.5% of the cases. SCCs and pre-neoplastic
actinic keratoses (AKs) occur primarily on chronically
sun-exposed sites of the body. UVB radiation (280-320 nm)
is the prevailing cause of DNA damage of the skin, which
may induce the progression of AKs to SCCs.1 Approximately
20% to 27% of SCCs arise in an AK or at a location that is
nearby. Approximately 53,410 men and 60,440 women in
Brazil were estimated to develop non-melanoma skin cancers
as SCCs and basal-cell carcinoma (BCCs) in 2010.2
Approximately 90% of SCCs bear mutation signatures at
dipyrimidic sites (C:G to T:A or CC:GG to TT:AA),
particularly at the hotspots of the TP53 gene, which result
in the inactivation of p53’s functions in cell-cycle arrest at
checkpoints, in DNA repair, or in the induction of apoptosis.
An early occurrence of TP53 mutations has been associated
with genomic instability and carcinogenic progression.1
Microsatellites are short, repeated sequences that are
present at specific loci that frequently exhibit allelic poly-
morphisms (heterozygosity) and are useful as genetic markers
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for tumors. A gain or loss of internal repeats causes
microsatellite instability (MSI), whereas the lack of an entire
microsatellite results in loss of heterozygosity (LOH). MSI is
associated with skin tumorigenesis3 and has also been shown
to be an important factor in the cis-regulation of transcription.4
Alterations to several chromosomes (3p, 9p, 9q, 13q, 17p,
and 17q) have been detected in SCCs. For example, the LOH
at the 17p13.1 TP53 locus is an early event in tumor
development and is consistent with the transition from AKs
to noninvasive SCCs.5 Other microsatellite markers, which
are located in the short (9p21) and long (9q22.3) arms of
chromosome 9, exhibited LOH and/or MSI alterations in the
AKs and SCCs. The number of alterations in 9p21 increased
in the SCCs compared with the AKs; however, in both
diseases, the incidence of MSI and LOH was similar. Other
studies detected 14 LOHs and two MSIs in 27 SCCs for at
least one microsatellite marker at 9p21 and detected
mutations in the CDKN2A and CDKN2B tumor-suppressor
genes. Specifically, the D9S50 exhibited six LOHs in 16
SCCs.6 Mortier et al.7 suggested that the malignant
progression of AKs to SCCs is associated with the increased
frequency of LOH at 9p21 and 17p in SCCs. A more recent
study detected one LOH and five MSIs in 26 AK samples for
at least one microsatellite marker at this locus.8 Our
previous study on SCCs exhibited one LOH in four SCCs
at the D9S50 and at 9p21.9 The mutations that were
observed in the CDKN2A, CDKN2B, and TP53 genes and
the reduced expression of the CDKN2A gene in the SCCs,
compared with that in the AKs, reinforced the assumptions
of many authors about the involvement of these genes in the
progression of AKs to SCCs.
The genetic hallmark for the development of BCCs,
another non-melanoma skin cancer, is the abrogation of
the patched/sonic hedgehog pathway, which specifically
involves the PTCH1 locus at 9q22.3-q31. Higher rates of
LOH at 9q, 9p and 17p were found in AKs, rather than in
invasive SCCs.10 D9S180 presented one MSI and one LOH
out of 12 SCCs;11 an LOH in D9S180 was also detected in
one out of two AKs and in two out of four SCCs. Regarding
D9S287, a LOH was detected in one out of two AKs but was
not detected in any SCCs.12
In contrast to the microsatellite analysis method, the
RAPD (random amplified polymorphic DNA) method
detects genetic alterations in the entire genome using single
primers that are composed of ten arbitrary oligomers and
give rise to personal fingerprints.13 An analysis of 30 head
and neck SCCs with 10 primers detected alterations in 100%
of the samples with at least one RAPD primer. There was a
significant correlation between the tumor stage and the
frequency of alteration.14
Our previous study on SCCs and AKs indicated the presence
of altered RAPD fingerprints with OPA-2 and OPB-15 primers
in 100% of the samples, compared with normal tissues.9
The results of this previous study encouraged us to
investigate the genomic instability of repetitive DNA in an
enlarged cohort of AKs, SCCs, and matched normal tissues
using eight primers for RAPD and nine for microsatellites.
MATERIAL AND METHODS
Tissues and DNA extraction
The DNA was extracted from eight AKs and 24 SCC
lesions (10 SCC-I, 10 SCC-II, and four SCC-III).
Supplementary Table 1s provides the following character-
istics of the studied patients: the identification number
attributed to each patient in the laboratory list, age, sex,
body site of the tumor, and associated skin tumors. The
tumors and paired adjacent normal tissues or blood
leucocytes were obtained from patients who were diag-
nosed and treated in the Outpatient Clinics of the
Department of Dermatology, Faculdade de Medicina da
Universidade de Sao Paulo. These patients signed an
informed consent form, and the research was approved by
the Ethical Committee of the Institution (CAPPesq). The
procedure for extracting the DNA from the tumors included
biopulverization of the tumor tissues, digestion in TES
buffer (10 mM Tris pH 8.0, 10 mM EDTA, 0.6% SDS) that
contained proteinase K 100 ug/ml at 50 C˚ for 3-4 h, DNA
extraction with phenol/chloroform/isoamyl alcohol, and
ethanol precipitation. This procedure was performed
according to standard protocols. Leucocytes were included
in the present study to evaluate the possible differences
between the repetitive patterns that were present in this
type of normal tissue and the normal skin that surrounded
each tumor. Following the lysis of the red blood cells (in a
10x buffer that consisted of 1550 mM NH4Cl, 100 mM
KHCO3, and 10 mM EDTA), the leucocytes’ DNA was
extracted as described above. The malignancy grading of
the SCCs was defined, according to the Broders classifica-
tion,15 as either well differentiated (SCC-I), moderately
differentiated (SCC-II), or poorly differentiated (SCC-III).
Microsatellites
Nine microsatellite primers were used to amplify the
DNA sequences that were located in the human chromo-
somes 6 and 9 by PCR to verify the genomic instability that
was related to these chromosomal sites. The following
microsatellites were studied: D6S251 and D6S252, which are
located at 6q14-16; D9S15, which is located at 9q21.11, a
highly repetitive chromosomal region; D9S50 and D9S52,
which are located at 9p21, near the CDKN2A and CDKN2B
genes; D9S180, D9S280, and D9S287, which are located
downstream to the PTCH1 gene at 9q22.3; and D9S196,
which is located upstream of the PTCH1 gene. The PCR
analyses were conducted in a final volume of 50 ml,
containing 10 pM of each primer, 100 ng DNA, 10X PCR
buffer, 1.5 mM MgCl2, 0.2 mM dNTP mix, and 1 unit Taq
DNA polymerase (LGC Biotechnology). The thermocycling
conditions consisted of 40 cycles of 1 min at 96 C˚, with
variable annealing temperatures (Table 1) and an extension
of 1 min at 72 C˚. The PCR products were resolved and
visualized on a silver-stained 7% polyacrylamide gel. When
the signal intensity of the band from the tumor DNA was
reduced by 50% or greater, it was considered to be
indicative of an LOH. Bands with decreased or increased
sizes were defined as examples of an MSI. The images were
captured using the Kodak 1D 3.6 Scientific Imaging SystemH
under a UV light. The number of samples that were studied
for each microsatellite and the corresponding histological
grades are depicted in Supplementary Table 2s.
Random Amplified Polymorphic DNA
The RAPD primers OPA-2, OPA-7, OPA-13, OPA-17,
OPB-8, OPB-11, OPB-13, and OPB-19 (Operon Technologies,
Alameda, CA) were used to evaluate the whole-genome
instability of the cancer cells, compared with normal tissues.
The PCR analyses were conducted in a final volume of 30 ml
using 50 ng DNA, 10X PCR buffer, 2.5 mM MgCl2, 330 mM
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dNTP mix, and 1 unit Taq DNA polymerase (LCG
Biotechnology). The OPA or OPB primers (10 pM) were
added to the reaction mix, and the reaction included 45
cycles consisting of 1 min for denaturation at 94 C˚, 1 min at
a variable annealing temperature (Table 1), 1 min of
extension at 72 C˚, and a final extension of 5 min at 72 C˚.
The PCR-amplified fragments were visualized on an
ethidium bromide-stained 1.5% agarose gel and were
photographed under a UV light. The bands that did not
match the normal pattern and/or presented an enhanced
fluorescence signal following the ethidium bromide staining
were defined as having a ‘‘band gain.’’ Any missing or
weakly stained bands in the tumor pattern were counted as
having a ‘‘band loss.’’ The total number of the tumors/
controls that were studied with each RAPD primer and the
corresponding histological types are presented with the
results.
Statistical analysis. The number of alterations in the
repetitive DNA patterns of the tumors was compared with
that of the controls using the Fisher test, which was
included in the GraphPad InStat 3 Program. The
differences were considered to be significant at p#0.05.
RESULTS
Microsatellite analysis
Table 2 identifies the patients who presented LOHs and/
or MSIs and shows the total number of alterations in each
microsatellite that was detected in all of the samples, which
are illustrated in Fig. 1. Interestingly, two MSIs and two
LOHs were detected in a single SSC-I from patient 21, who
also exhibited one BCC. One and three MSIs were found in
one SSC-II and one SSC-III, respectively, with both tumors
being derived from patient 258, who also exhibited multiple
BCCs.
The AK or SCC samples did not exhibit alterations in
D9S15, D9S52, or D9S196. Furthermore, no microsatellite
alterations were observed in the associated BCC that was
present in patients 261, 274, and 275.
The patients bearing SCCs of grades I, II, and III
exhibited a greater number of LOHs and/or MSIs than
did those bearing AKs, with two alterations in eight AKs,
four alterations (in a single tumor) in 10 SCC-Is, three
alterations in 10 SCC-IIs, and four alterations (in two
tumors) in four SCC-III being observed. However, the
results were not significant when the differentiation grades
of the SCCs were considered. D6S251 was the most altered
microsatellite (p= 0.0398), exhibiting six alterations in 30
samples (20%).
Table 2 - The patients who carried MSI or LOH mutations
were indicated for each microsatellite, according to their
laboratory list number. The bottom row indicates the
total number of alterations found in all of the patients
with informative results. (*) The total alterations of
D6S251 were significantly greater in the SCC (I+II+III)
compared with the AK lesions (p= 0.0398).
D6S251 D6S252 D9S50 D9S180 D9S280 D9S287
LOH MSI MSI MSI MSI MSI LOH
AK 1/8 201 261
SCC-I
1/8
21 21 21 21
SCC-II
3/10
22, 234 258
SCC-III
2/4
258 258 258 239
6/30* 1/33 1/31 2/30 2/26 1/31
Table 1 – The RAPDs and microsatellites studied, including the primer sequences, PCR annealing temperatures,
chromosomal locations and polymorphism ranges in base pairs (bp).*
Markers Primers sequences Annealing t ˚ Chromosome
D6S251 59- TTCCTAACCAGGTTTCAATG -39 51˚C 6q14-16
(GT)n 59- ATATTTTTAAAGTAAGTTGCAC -39 144-162 bp*
D6S252 59- ATGGCTCAGGATTCACATTG -39 53˚C 6q14-16
(GT)n 59- TGAAAGGAAAGTCCTGCTTC -39 154-166 bp*
D9S15 59- TAAAGATTGGGAGTCAAGTA -39 55˚C 9q13-21
(CA)n 59- TTCACTTGATGGTGGTAATC -39 195-209 bp*
D9S50 59- GATCCTTTTCATCTTCTGAC -39 52˚C 9p21
(CAGT)n 59- GAGGGACGGAGCAACTGAT -39 76-100 bp*
D9S52 59- GCTAGAGGGAGGTTTAATTG -39 54˚C 9p21
(ATTT)n 59- AATTAGCCAGGTGTTGTGGT -39 213-229 bp*
D9S180 59- CAGTGGTTTGGAATCGAACC -39 55˚C 9q22.3
(CA)n 59- AGCTATTTTTGGGGGCTGAG -39 220-230 bp*
D9S196 59- GGGATTACACCTCAAAACCA -39 55˚C 9q22.3
(CA)n 59- ACCACACTGCGGGACTT -39 254-260 bp*
D9S280 59- TTTCGCTTCCCACCCA -39 55˚C 9q22.3
(CA)n 59- CACGCCACTGATCTAGGCT -39 140-160 bp*
D9S287 59- GGATGCTCCTCACGC -39 55˚C 9q22.3
(CA)n 59- ACCACTACATTGTTCAAGGG -39 168-180 bp*
OPA-2 59- TGCCGAGCTG -39 34˚C
OPA-7 59- GAAACGGGTG -39 35˚C Unspecific
OPA-13 59- CAGCACCCAC -39 34˚C fingerprints,
OPA-17 59- GACCGCTTGT -39 32˚C concerning the
OPB-8 59- GTCCACACGG -39 34˚C whole genome;
OPB-11 59- GTAGACCCGT -39 32˚C sizes of the
OPB-13 59- TTCCCCCGCT -39 32˚C variable bands
OPB-19 59- ACCCCCGAAG -39 34˚C
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RAPD ANALYSIS
The number of RAPD bands in the SCCs tended to be
greater than that of the AKs; however, these differences
were not statistically significant (data not shown).
In general, the OPA-2 and OPA-13 patterns were highly
conserved, whereas the other primers resulted in more
variable fingerprints. Two AKs, one SCC-I, and one SCC-II
were not altered compared to the corresponding control.
Various lesions that were present in the same patient had
distinct patterns, indicating that unrelated genetic changes
were present among these tumors. The AKs’ patterns were
more similar to those of the controls than to those of the
SCCs that were present in the same patient, confirming the
presence of increased alterations during the progression of
malignancy. Figure 2 and Supplementary Figure 1s show
the other representative RAPD patterns. Several differences
in patterns that were observed between the leucocytes and
the adjacent skin tissues (Fig. 2) may be accounted for by the
normal genomic rearrangements that result in the various T-
cell lineages that are present in the blood.
Table 3 lists the absolute numbers and percentages of
tumors with altered fingerprints (as compared with normal
tissues), taking into consideration the total number of
samples that were studied with each primer. The mean
value ¡ the standard deviation of the altered fingerprints
was 0.7075¡0.08992 for AK, 0.7588¡0.04291 for SCC-I,
0.9063¡0.04625 for SCC-II, and 0.9950¡0.001890 for SCC-
III. The statistical analysis (t-tests and non-parametric tests)
indicated significant results for AK versus SCC-III
(p = 0.0065), SCC-I versus SCC-II (p= 0.0347), and SCC-I
versus SCC-III (p,0.0001). Two of the associated BCCs that
were studied were found to be altered when they were
investigated with OPA-7, OPA-17 and OPB-8 primers, but
not when they were investigated with OPA-2 primers (not
shown).
DISCUSSION
Repetitive DNA patterns were investigated to determine
the possible markers that were associated with the
malignant transformation of AKs to SCCs.
Figure 1 - The D6S251, D6S252, D9S50, D9S180, D9S280, and
D9S287 microsatellites were visualized on a silver nitrate-stained
polyacrylamide gel. Patient identification (bold numbers).
Leucocytes (b), normal tissue (n), actinic keratosis (AK), and
squamous cell carcinoma (SCC) grades I, II, and III. (*) LOH, (**)
MSI, (M) Molecular marker (bp).
Figure 2 - The RAPD patterns that were obtained using primers
OPA-2, OPA-13, OPA-17, and OPB-11 were visualized on an
ethidium bromide-stained gel. Several bands that were altered in
the tumors are indicated (kb). The abbreviations are as indicated
in Fig. 1.
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Among the nine microsatellites that were studied, D6S251
was the most altered in the SCC lesions, followed by D9S180
and D9S280 (Table 2). D6S252 demonstrated only one MSI in
one SCC-III. Our previous BCC studies also identified a
greater number of alterations in D6S251 than in D6S252.
One study of BCCs found a 60% MSI and a 10% LOH in
D6S251 and only a 10% MSI in D6S252.16 Another study
detected a 7.6% MSI and a 15% LOH in D6S251 in the high-
risk BCCs but detected no alterations in D6S252.17 On the
contrary, D6S252 exhibited a 30% MSI, and D6S251
exhibited only a 9% LOH in an MM study (Lozano L.F.,
Master Thesis, 2009).18
Reports of altered D6S251 and D6S252 sequences in AK and
SCC genomes were not found in the literature, and no genes
related to SCC development have been observed adjacent to
these microsatellites. However, abnormalities in the 6q12-q21
chromosomal region have been extensively observed in
several cancer types, particularly in MM. Cytogenetic studies
have revealed complex rearrangements and deletions at 6q
and have revealed an LOH at the molecular level, suggesting
the existence of a putative suppressor gene that may be found
farther down in this region.
For chromosomal region 9p, our previous study found an
LOH at D9S50 in one of the four SCCs.9 However, in the
present, large study of 22 SCCs, no alterations in this
microsatellite were detected, and only one MSI in seven
AKs was observed. Other studies detected an LOH in the
9p21 region in SCCs and AKs,7 which would have altered
the expression of the tumor-suppressor genes CDKN2A and
CDKN2B. These genes are involved in the progression of
AKs to SCCs.19 These genes did not seem to be related to the
malignant progression of our samples.
Mutations in the PTCH1 gene at 9q were associated with
the development of .70% of the BCCs and with the
development of SCCs in individuals with histories of
multiple BCCs.20 Alterations in the microsatellites that were
adjacent to PTCH1 may have affected the expression of the
PTCH1 protein in the SCCs but not in the AKs and BCCs,
which were not altered in these individuals.
Several authors have considered AK to be an initial step
of a spectrum of disease that leads to SCC; however, as
already mentioned, the data are controversial. Japanese
patients exhibited an LOH of several microsatellites in 19%
of the AKs and in 7% of the SCCs, but no MSIs were
observed. According to the authors of that study, these
results were not indicative of tumor progression from AKs
to SCCs, and the molecular pathogenesis in skin tumors
may be race- and geography-dependent.21 Other studies
have also observed LOHs at a higher frequency in AKs than
in SCCs, suggesting that AKs are not precursors to SCCs.5,9
Conversely, the AK samples that were studied in the
present work did not exhibit an LOH but observed two
MSIs, whereas the SCCs presented four LOHs and eight
MSIs. Padilla et al.22 have recently identified common genes
whose expression was up- or downregulated in AKs and
SCCs. However, these genetic characteristics were not
differentiated between the AKs and SCCs.
In addition to the microsatellite analysis, three RAPD
primers (OPA-2, OPA-7 and OPB-8) revealed 86% and 95%
alterations in the AKs and SCCs, respectively. Our previous
data indicated that 100% alterations occurred with the
primers OPA-2 and OPB-15 in all of the skin-lesion types,
including AKs, SCCs, BCCs, MM, and MN (melanocytic
nevus).9
Overall, these results demonstrated highly conserved
RAPD patterns in SCCs from various patients, and
especially in the case of AKs (cf. Fig. 2, OPA-2 and OPA-
13, and Supplementary Figure 1s). The total number of
alterations in the RAPD patterns was, in all cases, greater in
the SCCs than AKs when compared with the patterns that
were observed in the corresponding normal tissues
(p,0.01). A significant correlation between the SCCs’
malignancy grading and the frequency of the RAPD
alterations was observed. Maeda et al. described the
genomic instability using at least one RAPD primer in
100% of the head and neck SCCs and also observed a
significant correlation with the tumor differentiation
degree.14 A similar correlation was also observed in
hepatocellular carcinomas23 and breast cancers.24
Because the differences between the numbers of gained
and lost bands in the fingerprint profiles were not
statistically significant, the putative rearrangements of the
tumor genomes must have been balanced, without prefer-
ential increases or losses of genetic material. The type of
genomic rearrangements that result in altered tumor
fingerprints should be investigated by isolating, cloning,
and sequencing the particular bands that were missing or
were newly found in the DNA patterns of several patients.
Further analyses of these DNA fragments may yield
significant information regarding the molecular mechan-
isms of SCC development and may eventually reveal new
biomarkers. The overall alterations that were found in the
repetitive DNA patterns in the present study reinforce the
assumption of a spectrum of malignant progression from
AKs to SCCs.
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